Findings

What do systematic reviews say?

3 questions · 4 findings · 3 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Probiotics used as adjuvants to conventional antifungal drugs vs conventional antifungal drugs

Rate of serious adverse events · non‐pregnant women with vulvovaginal candidiasis

Probiotics used as adjuvants to conventional antifungal drugs showed no clear difference in rate of serious adverse events compared with conventional antifungal drugs (low certainty).

1 finding from 1 review

Probiotics for vulvovaginal candidiasis in non‐pregnant women 2017 · Cochrane Headline outcomes only
RR 0.8 [0.22, 2.94]
2 studies · 440 participants
Low

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

Rate of serious adverse events · patients with chronic heart failure with preserved ejection fraction

2 findings from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 179 participants
Low
Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Rate of serious adverse events · patients with acute ischaemic or haemorrhagic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic therapy for preventing infections in people with acute stroke 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found